Healios K.K. to Present at the 2025 Jefferies Global Healthcare Conference NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City as follows: Date & Time: Thursday, June 5, 2025 2:35pm, Eastern Standard Time (US) Webcast: To schedule a 1x1 meeting with Healios, please contact your Jefferies representative at . The live and archived webcast will be accessible from Jefferies’ website. The replay of the webcast will...
HEALIOS KK (JP), a company active in the Biotechnology industry, now shows a lower overall rating. The independent financial analyst theScreener just confirmed the fundamental rating of 4 stars out of 4, as well as the stock market behaviour of the title as moderately risky. However, environmental deterioration penalises the general evaluation, which is downgraded to Neutral. As of the analysis date July 2, 2021, the closing price was JPY 1,839.00 and its expected value was estimated at JPY 1,75...
The independent financial analyst theScreener just awarded an improved star rating to HEALIOS KK (JP), active in the Biotechnology industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 2 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as moderately risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date February 19, 2021, the ...
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.